ArticleDiabetes2017

Inhibition of Renal Sodium-Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose.

Muhammad Abdul-Ghani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.